TL 211 (Cyclobenzaprine Hydrochloride 5 mg)
Pill with imprint TL 211 is Orange, Round and has been identified as Cyclobenzaprine Hydrochloride 5 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Cyclobenzaprine is used in the treatment of sciatica; muscle spasm and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy. Cyclobenzaprine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TL 211





Cyclobenzaprine Hydrochloride
- Imprint
- TL 211
- Strength
- 5 mg
- Color
- Orange
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Skeletal muscle relaxants
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- Inactive Ingredients
-
silicon dioxide, croscarmellose sodium, lactose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, magnesium silicate, titanium dioxide, ferric oxide yellow, FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
51991-0467 | Breckenridge Pharmaceutical, Inc. |
59746-0211 | Jubilant Cadista Pharmaceuticals Inc. |
63874-1186 | Altura Pharmaceuticals Inc. (repackager) |
54868-5597 | Physicians Total Care Inc. (repackager) |
Related Images for "TL 211"
More about cyclobenzaprine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 521 Reviews
- Drug class: skeletal muscle relaxants
- FDA Alerts (1)
Consumer resources
- Cyclobenzaprine
- Cyclobenzaprine (Advanced Reading)
- Cyclobenzaprine Tablets
- Cyclobenzaprine Extended-Release Capsules
Other brands: Flexeril, Amrix, Comfort Pac with Cyclobenzaprine, Fexmid
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.